Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement

Anteris Technologies Ltd

Research and development of our Structural Heart products. Products under development include DurAVR, a novel and highly durable 3D single piece aortic valve for the treatment of aortic stenosis. Combined with the ADAPT technology this design delivers better haemodynamic performance through unique properties that are critical to longer lasting valves; and manufacture and sale of proprietary ADAPT regenerative tissue products globally.

AVR$23.000
 -0.100 -0.43%

Data last updated:Apr 24, 2024 – 4.10pm. Data is 20 mins delayed.

Announcements